The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
Y Shimazu, J Kanda, K Suzuki, A Wada… - Cancer …, 2024 - Wiley Online Library
The anti‐CD38 antibody daratumumab (Dara) has been reported to improve the prognosis
of multiple myeloma (MM) patients, but its use before autologous stem cell transplantation …
of multiple myeloma (MM) patients, but its use before autologous stem cell transplantation …
[PDF][PDF] Factors affecting prognosis of MGUS and multiple myeloma
K Lemonakis - 2024 - portal.research.lu.se
Multiple myeloma (MM) is a malignant plasma cell disease preceded by an asymptomatic
state called monoclonal gammopathy of undetermined significance (MGUS). Although …
state called monoclonal gammopathy of undetermined significance (MGUS). Although …
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
J Kanda, Y Shimazu, K Suzuki, A Wada, T Kikuchi… - 2023 - researchsquare.com
The anti-CD38 antibody daratumumab (Dara) has been reported to improve the prognosis of
multiple myeloma (MM) patients, but its use before autologous stem cell transplantation …
multiple myeloma (MM) patients, but its use before autologous stem cell transplantation …